The Cooper Companies Reports Strong Q1 2026 Earnings with Raised Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy COO?
Source: seekingalpha
- Strong Financial Performance: The Cooper Companies reported consolidated revenues of $1.024 billion for Q1 2026, reflecting a 6.2% year-over-year increase, with CooperVision revenue at $695 million, up 7.6%, indicating robust market performance and profitability.
- Free Cash Flow Growth: The company achieved $159 million in free cash flow during Q1, showcasing successful operational efficiency and capital allocation, leading management to raise the 2026 free cash flow guidance to $600 million to $625 million, demonstrating confidence in future growth.
- Progress on Strategic Priorities: CEO Albert White emphasized significant advancements in market share, operational excellence, and disciplined capital allocation, particularly in product launches and adoption in EMEA and Japan, highlighting the company's competitive edge in global markets.
- Optimistic Future Outlook: Management anticipates consolidated revenues of approximately $4.3 billion to $4.35 billion for fiscal 2026, reflecting organic growth of 4.5% to 5.5%, indicating that strategic investments and innovation will drive long-term growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COO
Wall Street analysts forecast COO stock price to rise
12 Analyst Rating
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 81.980
Low
73.00
Averages
90.33
High
100.00
Current: 81.980
Low
73.00
Averages
90.33
High
100.00
About COO
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strong Financial Performance: The Cooper Companies reported consolidated revenues of $1.024 billion for Q1 2026, reflecting a 6.2% year-over-year increase, with CooperVision revenue at $695 million, up 7.6%, indicating robust market performance and profitability.
- Free Cash Flow Growth: The company achieved $159 million in free cash flow during Q1, showcasing successful operational efficiency and capital allocation, leading management to raise the 2026 free cash flow guidance to $600 million to $625 million, demonstrating confidence in future growth.
- Progress on Strategic Priorities: CEO Albert White emphasized significant advancements in market share, operational excellence, and disciplined capital allocation, particularly in product launches and adoption in EMEA and Japan, highlighting the company's competitive edge in global markets.
- Optimistic Future Outlook: Management anticipates consolidated revenues of approximately $4.3 billion to $4.35 billion for fiscal 2026, reflecting organic growth of 4.5% to 5.5%, indicating that strategic investments and innovation will drive long-term growth.
See More
- Earnings Beat: The Cooper Companies reported a Q1 non-GAAP EPS of $1.10, exceeding expectations by $0.07, indicating robust profitability that may enhance investor confidence.
- Stable Revenue Growth: Revenue for the quarter reached $1.02 billion, reflecting a 5.7% year-over-year increase, aligning with market expectations and demonstrating the company's ability to maintain stable sales in a competitive environment.
- Improved Operating Margin: Operating margin increased from 19% last year to 21%, driven by operating expense leverage, showcasing the company's success in cost control and efficiency improvements.
- Strong Free Cash Flow: With cash provided by operations at $260.9 million and capital expenditures of $102.2 million, the free cash flow stood at $158.7 million, reflecting the company's strong cash generation capability and providing ample funding for future investments.
See More
- Profit Growth: The Cooper Companies reported a first-quarter profit of $130.8 million, or $0.66 per share, marking a significant increase from last year's $104.3 million and $0.52 per share, indicating strong market performance and enhanced profitability.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $217.0 million, or $1.10 per share, reflecting the robustness of its core business and improved earnings quality, which may bolster investor confidence.
- Revenue Increase: Revenue for the quarter rose 5.7% to $1.02 billion from $964.7 million last year, demonstrating the company's ability to achieve sales growth amid recovering market demand, further solidifying its market position.
- Full-Year Guidance: The Cooper Companies provided full-year EPS guidance of $4.58 to $4.66 and revenue guidance of $4.306 billion to $4.346 billion, indicating a positive outlook for future performance that could attract more investor interest.
See More
- Costco Earnings Beat Expectations: Costco reported Q2 earnings of $4.58 per share on $69.6 billion in revenue, surpassing analyst expectations of $4.56 and $69.29 billion, with membership fees rising 13.6% year-over-year to $1.36 billion, indicating strong customer loyalty and spending power.
- Marvell's Strong Performance: Marvell Technology saw a nearly 9% share increase as Q4 adjusted earnings reached $0.80 per share on $2.22 billion in revenue, exceeding analyst forecasts of $0.79 and $2.21 billion, with management projecting continued revenue growth each quarter in fiscal 2027, reflecting robust demand for its products driven by AI.
- Gap's Earnings Miss: Gap's stock fell almost 8% after reporting Q4 earnings of $0.45 per share, slightly below the $0.46 expected by analysts, although revenue of $4.24 billion met expectations, raising concerns about its profitability and market position.
- Samsara's Positive Outlook: Samsara's shares surged over 11% after providing optimistic guidance, forecasting full-year adjusted earnings between $0.65 and $0.69 per share and revenue between $1.97 billion and $1.98 billion, both exceeding market expectations, while also leveraging AI to enhance operational efficiency, showcasing its innovative potential.
See More
- Earnings Announcement: The Cooper Companies (COO) is set to release its Q1 2023 earnings on March 5 after market close, with consensus EPS estimates at $1.03, reflecting a 12% year-over-year increase, and revenue estimates at $1.02 billion, up 5.7%, indicating solid market performance.
- Historical Performance: Over the past two years, COO has beaten EPS estimates 100% of the time and revenue estimates 38% of the time, showcasing its strong ability in profitability and market expectation management, which boosts investor confidence.
- Estimate Revision Trends: In the last three months, EPS estimates have seen 10 upward revisions and 2 downward revisions, while revenue estimates experienced 2 upward and 4 downward revisions, reflecting mixed market sentiment regarding the company's future performance, which could impact stock price volatility.
- Strategic Cash Flow Target: The Cooper Companies has raised its free cash flow target to $2.2 billion by 2028, aiming to drive long-term growth through ongoing strategic reviews, thereby enhancing its competitive position in the healthcare sector.
See More








